Breast Cancer Trial, Recruiting (NCT06524895)

Breast Cancer Trial, Recruiting NCT06524895 Sponsor: Albert Einstein College of Medicine Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06524895 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 to 99 years old
People who have been diagnosed with breast cancer at Stage 0 through Stage III
People who are scheduled to have a mastectomy (removal of one or both breasts, with or without reconstruction) within 2 weeks of being recruited into the trial
People who speak English
People who live within 50 miles of Bronx County, New York

Who may not be able to join:

People who currently have a psychiatric or mental health condition that is not being controlled or managed
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alyson Moadel, PhD, Albert Einstein College of Medicine

Phone: (718)430-2696

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06524895

Sponsor: Albert Einstein College of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: (718)430-2696

More information: https://clinicaltrials.gov/study/NCT06524895

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 to 99 years old
People who have been diagnosed with breast cancer at Stage 0 through Stage III
People who are scheduled to have a mastectomy (removal of one or both breasts, with or without reconstruction) within 2 weeks of being recruited into the trial
People who speak English
People who live within 50 miles of Bronx County, New York

Who may not be able to join:

People who currently have a psychiatric or mental health condition that is not being controlled or managed
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Albert Einstein College of Medicine

Registry

ClinicalTrials.gov

Start date

9 November 2022

Est. completion

1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility based on Number Screened for Inclusion; Feasibility - Percentage of Patients who met Inclusion Criteria; Feasibility - Percentage of Patients who Assented for Informed Consent; Feasibility - Percentage of Patients who Completed the Informed Consent Procedure; Feasibility - Percentage of Patients who Agreed and Refused to Participate; Feasibility - Percentage of Patients who Completed Baseline Assessments; Feasibility - Percentage of Patients who were Randomly Allocated as per allocation list to Treatment Arm; Feasibility - Percentage of Patients who Received Intended Intervention;...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov